Page 53 - Eua News Today

HYDERABAD: Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Tuesday said it has scaled up its manufacturing capacities of Covaxin to 700 million doses per annum making it one of the largest production capacities for Inactivated viral vaccines globally. The company said the scale-up has been carried out across multiple facilities at Hyderabad, where it has facilities at Genome Valley, as well as Bangalore where its related entity Biovet Pvt Ltd has facilities at Malur. ...

all of the “vaccines” currently being administered for the Wuhan coronavirus (Covid-19) under Food and Drug Administration (FDA) emergency use authorization (EUA) cause blood clots. These include not just the jabs from AstraZeneca and Johnson & Johnson (J&J), which have received the most attention, but also those offered by Pfizer-BioNTech and Moderna – these later two contain messenger RNA (mRNA) technology that permanently alters a person’s DNA. Based on 795 reports from the latest d...

Synopsis The technology transfer process is well underway and IIL has the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment, it added. Agencies Inactivated vaccines, while highly safe, are extremely complex and expensive to manufacture, resulting in lower yields when compared to live virus vaccines, it noted. To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capaci...

Scientists confident about Covid-19 vaccine for children but not all parents agree Many are concerned that vaccine hesitancy in some adults will be even more pronounced when it comes to their children 17 April 2021 - 07:00 Gabriella Borter and Michael Erman A teenager receives a vaccination against the coronavirus disease in Tel Aviv, Israel, in this photo taken on January 24 2021. Picture: REUTERS/RONEN ZVULUN Tristen Sweeten, a 34-year-old nurse in Utah, hopes her three...

Russian Covid-19 vaccine Sputnik V In a boost for Indias nationwide COVID-19 inoculation drive, the first batch of Sputnik V COVID-19 vaccine will arrive from Russia in April itself, according to the Indian Ambassador to Russia Bala Venkatesh Varma, Livemint. Speaking to reporters, Ambassador Varma said that the first shipment will likely take place by the end of April and that the production of vaccine in India would begin in May and then slowly increase. He also said that the volume of the I...

HYDERABAD: Russian Covid-19 vaccine, Sputnik V, which received emergency use authorisation (EUA) earlier this week, will be available for use in India in the April-June quarter with imports coming in from Russia. Local manufacturing will kick in from the July-September quarter, top officials of Dr Reddy’s Laboratories said on Wednesday. “The first batches are going to be produced by RDIF (Russian Direct Investment Fund) and will be imported to India by us,” Dr Reddy’s Laboratories co-c...

Centre fast tracks Emergency Approvals for foreign produced Covid-19 Vaccines April 13, 2021 The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programmes within the country In a bid to tackle rising Covid cases, the centre has decided to give emergency use approval to the vaccines developed or being manufactured overseas and have already been given clearance for restricted use by the regulat...

India News: The Covid-19 task force on Tuesday recommended the government to authorise those foreign-produced Covid-19 vaccines which have been granted emergency

NEW DELHI: India on Monday granted Emergency Use Authorisation (EUA) to Russias anti-covid vaccine Sputnik V, as the country continues to reel under the second wave of coronavirus. The approval comes on the day India reported 168,912 new coronavirus cases in the last 24 hours to overtake Brazil as the second-most affected Covid-19 country in the world. Indias overall coronavirus tally has reached 13.53 million. The Subject Expert Committee (SEC) had met earlier last week and asked for more in...

New Delhi [India], April 1 (ANI): Russia's COVID-19 Sputnik V vaccine was denied emergency use authorisation in India on Thursday by the Subject Expert Committee (SEC) constituted by the central government.